Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board changes and trading update

30 Jan 2015 07:00

RNS Number : 5581D
Plant Health Care PLC
30 January 2015
 



30 Jan 2015

 

PLANT HEALTH CARE plc

 

("Plant Health Care" or the "Company")

 

Board changes and trading update

Plant Health Care announces organisation changes and a pre-close trading statement in respect of the year ended 31 December 2014.

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to the global agriculture markets, is pleased to announce that Dr. Richard Webb, formerly a Non-Executive Director, has become an Executive Director of Plant Health Care plc. Richard will be responsible for supporting the Chief Scientific Officer, Dr. Zhongmin Wei, as the company continues to expand its research and development programme.

Richard will step down from the Audit Committee and be replaced by James Ede-Golightly. In due course, the company intends to appoint an additional independent non-executive director with extensive commercial experience in the sector.

During 2014, the Company continued to make substantial progress in our core research objectives, as evidenced by the launch of the Innatus 3G™ technology platform. Major industry players have responded positively to Innatus 3G and we are in active discussions with them as we pursue potential partnerships. Our intellectual property portfolio continues to strengthen our leading position in protein-based bio-stimulants. Regarding our existing products, we have added material new distribution agreements over recent months, which we anticipate will lead to further sales growth as registrations are obtained outside current markets. We are actively exploring options to extend and accelerate sales further.

Revenue for the year ended 31 December 2014 amounted to $6.9 million, of which $0.15 million was one-off milestone payments. The company's sales of proprietary products (excluding one-off payments) grew 40% over 2013 with combined sales of Harpin and Myconate reaching $3.5 million.

Cash and investments at the year-end were $16.7 million.

More details will be provided in the announcement of the Company's 2014 results, scheduled for 30 March 2015.

- ENDS -

For further information, please contact:

Plant Health Care plc

Paul Schmidt, Chief Executive Officer Tel: +1 (919) 926 1600

 

Liberum Capital - Nomad and Broker

Clayton Bush Tel: +44 (0) 20 3100 2000

 

LHA

Ed McGregor / Jody Burfening Tel: +1 (212) 838 3777

 

Company website: www.planthealthcare.com

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEADFNAEESEAF
Date   Source Headline
1st Mar 201010:00 amRNSTotal Voting Rights
19th Feb 201010:30 amRNSDirector/PDMR Shareholding
16th Feb 201010:36 amRNSAdditional Listing and Directors' Shareholdings
16th Feb 20109:51 amRNSDual Listing on Channel Islands Stock Exchange
15th Feb 201012:26 pmRNSBlocklisting
15th Feb 20107:00 amRNSFinal Results
10th Feb 20107:00 amRNSSupply Agreement
4th Feb 20107:00 amRNSOrder for Myconate
2nd Feb 20107:00 amRNSTrial Results
1st Feb 201010:22 amRNSTotal Voting Rights
27th Jan 20107:00 amRNSTrading Statement
22nd Jan 20105:41 pmRNSAdditional Listing
12th Jan 20104:03 pmRNSDirector Declaration
31st Dec 20091:05 pmRNSTotal Voting Rights
29th Dec 20094:26 pmRNSAdditional Listing
8th Dec 20095:42 pmRNSAdditional Listing
1st Dec 200911:08 amRNSTotal Voting Rights
27th Nov 20092:55 pmRNSDirector/PDMR Shareholding
13th Nov 200911:52 amRNSHolding(s) in Company
10th Nov 20095:29 pmRNSAdditional Listing
6th Nov 200912:53 pmRNSAdditional Listing
4th Nov 20091:52 pmRNSAdditional Listing
2nd Nov 20091:29 pmRNSTotal Voting Rights
1st Oct 20094:21 pmRNSTotal Voting Rights
30th Sep 20095:31 pmRNSDirector/PDMR Shareholding
28th Sep 20096:21 pmRNSAdditional Listing
21st Sep 20099:47 amRNSPosting of Interim Results
21st Sep 20099:41 amRNSAdditional Listing
17th Sep 20096:01 pmRNSAdditional Listing
17th Sep 20095:06 pmRNSAdditional Listing
14th Sep 20097:05 amRNSSustainability Commendation
14th Sep 20097:00 amRNSInterim Results
9th Sep 20097:30 amRNSNotice of Results
1st Sep 200910:19 amRNSTotal Voting Rights
20th Aug 20092:58 pmRNSAdditional Listing
17th Aug 20097:00 amRNSExpansion of Partnership with Scotts
13th Aug 200912:55 pmRNSAdditional Listing
3rd Aug 200910:17 amRNSTotal Voting Rights
28th Jul 20093:05 pmRNSReplacement: Holding(s) in Company
28th Jul 200911:24 amRNSHolding(s) in Company
17th Jul 20091:39 pmRNSAdditional Listing
14th Jul 200912:59 pmRNSDirector/PDMR Shareholding
1st Jul 20097:01 amRNSRe: Monsanto announcement
1st Jul 20097:00 amRNSTotal Voting Rights
25th Jun 20097:00 amRNSSustainable Business 20
9th Jun 20098:35 amRNSDirector/PDMR Shareholding
5th Jun 200910:46 amRNSResult of AGM
4th Jun 20097:00 amRNSTechnical Presentation
3rd Jun 20099:17 amRNSSignificant Shareholding
2nd Jun 20097:00 amRNSMonsanto Order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.